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Abstract
Minimally invasive procedures are becoming increasingly more common in surgery. However, the 
biomaterials capable of delivering biomimetic, three-dimensional (3D) functional tissues in a 
minimally invasive manner and exhibiting ordered structures after delivery are lacking. Herein, we 
reported the fabrication of gelatin methacryloyl (GelMA)-coated, 3D expanded nanofiber scaffolds 
and their potential applications in minimally invasive delivery of 3D functional tissue constructs 
with ordered structures and clinically appropriate sizes (4 cm × 2 cm × 1.5 mm). GelMA-coated, 
expanded 3D nanofiber scaffolds produced by combining electrospinning, gas-foaming expansion, 
hydrogel coating, and crosslinking are extremely shape recoverable after release of compressive 
strain, displaying a superelastic property. Such scaffolds can be seeded with various types of cells, 
including dermal fibroblasts, bone marrow-derived mesenchymal stem cells, and human neural 
stem/precursor cells to form 3D complex tissue constructs. Importantly, the developed 3D tissue 
constructs can be compressed and loaded into a 4-mm diameter glass tube for minimally invasive 
delivery without compromising the cell viability. Taken together, the method developed in this 
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study could hold great promise for transplantation of biomimetic, 3D functional tissue constructs 
with well-organized structures for tissue repair and regeneration using minimally invasive 
procedures like laparoscopy and thoracoscopy.
Keywords
expanded nanofiber scaffolds; stem cells; 3D tissue constructs; ordered structure; minimally 
invasive delivery
Based on tissue engineering and regenerative medicine principles, three-dimensional (3D) 
tissue constructs with a variety of functions and complex structures have been established 
for surgical transplantations to repair many types of tissues, often necessitating invasive 
surgical procedures.1-4 However, invasive surgical implantations are associated with an 
increased risk for perioperative and postoperative complications (e.g., infections).5 
Researchers have attempted to develop other approaches for delivering cells in a minimally 
invasive manner (e.g., injection), including cell solutions, mixing cells with hydrogels, cell-
encapsulated hydrogel beads, cell-seeded microparticles/microspheres, cell aggregates/
organoids, cell microdroplets, and cell sheet fragments.6-15 However, these methods failed to 
supply 3D tissue constructs with specifically ordered structures and instantaneous 
functionality. Some of the approaches even led to low cell retention and survival rate and 
eventually failed to repair the targeted tissue defects after delivery.6,16 There is a great need 
to develop 3D functional tissue constructs with well-organized structures that can be 
delivered through minimally invasive procedures (e.g., without fully opening the chest).
Towards this end, several types of materials/scaffolds have been investigated for minimally 
invasive delivery of cells/tissues. Interconnected macroporous cryogels made of alginate, 
gelatin, hyaluronic acid (HA), HA-co-gelatin, and poly(ethylene glycol) diacrylate 
(PEGDA) with shape-memory properties were reported in many predefined geometries, 
which can be rehydrated with a suspension of cells (e.g., chondrocytes, mesenchymal stem 
cells (MSCs), fibroblasts, and neurons) and/or growth factors (e.g., vascular endothelial 
growth factor (VEGF)) and compressed into smaller forms and delivered through a small 
catheter or syringe injection for enhancing cell retention and revascularization.17-19 Porous 
collagen-coated carboxymethylcellulose microscaffolds seeded with OP9 mesenchymal cells 
and hematopoietic stem and progenitor cells (HSPCs) after in vitro co-culture were 
harvested as a paste-like living injectable niche through precisely controlled dehydration, 
preserving HSPC function.20 Flexible shape-memory poly(oxymethylene maleate 
(anhydride) citrate) scaffolds fabricated using a combination of conventional soft 
lithography and injection molding were seeded with cardiomyocytes to form cardiac patches 
(1 cm × 1 cm × 0.1 mm), which can regain their initial shape without influencing cell 
survival and function after delivery through a small orifice.21 Other than the shape-memory 
scaffolds, heart valve scaffolds made of polyglycolide acid mesh coated with poly-4-
hydroxybutyrate with seeding of myofibroblasts were delivered in a minimally invasive 
manner in combination with self-expandable stents.22 However, these scaffolds are 
associated with issues, including lack of extracellular matrix (ECM)-mimetic topography, 
absence of aligned nanotopographic cues, limited size and thickness (non-clinically relevant 
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size and thickness), and/or necessitating the assistance from self-expandable stents. The 
aligned nanotopographic cues are essential for the repair of tissues (e.g., muscle, nerve, and 
tendon) with ordered structure. These tissues show an anisotropic characteristic of ECM 
topography. Aligned nanotopographic cues play an important role in regulating cell 
morphology and function and guiding ECM deposition. It is critical to use the constructs 
with ordered structure for repairing tissues like muscle, nerve, and tendon.
Here, we describe a new method for minimally invasive delivery of biomimetic, 3D 
functional tissue constructs with ordered structures with clinically relevant size and 
thickness for tissue repair as illustrated in Figure 1. The tissue constructs were built based on 
3D expanded electrospun nanofiber scaffolds produced by our two recent vital findings. One 
is that innovative gas-foaming technology can expand 2D electrospun nanofiber mats to 
form 3D expanded scaffolds with layered structure and controlled alignment.24,25 Briefly, 
NaBH4 reacting with water produced H2 gas bubbles within nanofiber membranes. As the 
reaction proceeded, the H2 gas bubbles grew and/or merged, resulting in the expansion of 
nanofiber membranes. The other is that gelatin coating allows expanded nanofiber scaffolds 
to be superelastic, compressible, and shape recoverable.26 We hypothesized that i) stem cells 
(e.g., bone marrow-derived mesenchymal stem cells (BMSCs) and human neural stem/
progenitor cells (hNSCs)) could be seeded on 3D expanded nanofiber scaffolds and 
proliferate and/or differentiate throughout the scaffolds to form 3D tissue constructs; ii) the 
engineered 3D tissue constructs could be compressed and delivered to damaged/diseased 
tissue sites using minimally invasive surgical procedures such as laparoscopy and 
thoracoscopy;26,27 iii) the delivered tissue constructs can return to their original shape after 
delivery, and the shape-recovered 3D tissue constructs could effectively repair the damaged 
tissues (Figure 1).
To test our hypothesis, we first fabricated 3D expanded nanofiber scaffolds. Briefly, 1-mm 
thick poly(ε-caprolactone) (PCL) nanofiber stripes (4 cm × 1.5 mm) were generated by 
electrospinning and cryocutting following our previous studies.28-30 Then, the stripes were 
expanded in the NaBH4 solution to form 2-cm wide scaffolds. The expanded 3D scaffolds 
were further coated with the 0.05% gelatin methacryloyl (GelMA) solution followed by 
crosslinking to enhance their mechanical properties and maintain the nanofibrous 
morphology. Figure 2a shows photographs of electrospun nanofiber stripes (4 cm × 1 mm × 
1.5 mm). Figure 2b shows the photographs of 3D expanded nanofiber scaffolds in different 
views, indicating the clinically relevant dimensions (4 cm × 2 cm × 1.5 mm) for a cardiac 
patch.31 Figure 2c shows scanning electron microscopy (SEM) images of expanded PCL 
nanofiber scaffolds, indicating the porous structure and alignment of fibers. Figure 2d shows 
SEM images of expanded PCL nanofiber scaffolds after 0.05% GelMA coating and freeze-
drying. Intriguingly, part of the coated GelMA formed nanofibers throughout the expanded 
scaffold, resulting in a hybrid nanofiber scaffold (Figure S1). In contrast with PCL 
nanofibers, the GelMA nanofibers were randomly distributed and the diameter of GelMA 
nanofibers was not uniform (Figure S1). In contrast, a mass of GelMA sheets and small 
amount of GelMA nanofibers were seen throughout the expanded scaffold after 0.1% 
GelMA coating (Figure S2). The mechanism of GelMA nanofiber formation could be 
similar to the formation of nanofibers by freeze-drying dilute polymer solutions reported in 
previous studies as the GelMA concentration was 0.05%.32 As described, during freeze-
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drying of a dilute solution, the polymer molecules could be excluded to form nanofibers 
because of the small number of polymer molecules available. In addition, a small amount of 
GelMA could be directly coated on the surface of PCL nanofibers without altering the 
original nanofibrous morphology. We then characterized the superelastic and shape 
recoverable properties of 0.05% GelMA coated, 3D expanded nanofiber scaffolds. Figure 3a 
shows that 0.05% GelMA coated, 3D expanded PCL nanofiber scaffolds can return to their 
original shapes after compression, pulling, rolling, and folding. The cyclic compression tests 
further confirmed their superelastic and shape recoverable properties. The 3D expanded 
nanofiber scaffolds without GelMA coating deformed after one time of compression in 90% 
compressive strain (Figure 3b). As expected, the GelMA-coated nanofiber scaffolds could 
return to their original shapes even after 100 times of compression with 90% compressive 
strain (Figure 3c). The GelMA coating significantly enhanced the compressive stress of 3D 
expanded nanofiber scaffolds in 50%, 70%, and 90% compressive strains, respectively 
(Figure 3d). Though the elastic modulus of GelMA-coated nanofiber scaffolds slightly 
decreased during the 100 cycles of cyclic compression in 90% compressive strain, the elastic 
modulus of GelMA-coated scaffolds were much higher than those of the scaffolds without 
coating at the 1st, 25th, 50th, 75th, and 100th cycle of cyclic compression (Figure 3e). In 
addition, the GelMA-coated scaffold was able to recover its original shape in water after 
compression (Video S1). To understand the mechanism of superelastic and shape 
recoverable properties, we performed SEM imaging of cross-sections of 3D expanded 
nanofiber scaffolds without and with GelMA coating under compression in different 
compressive strains (Figure 3f and 3g). The cross-sections of 3D expanded nanofiber 
scaffolds with and without GelMA coating exhibited many arch-shaped pores. After 
compression in 50%, 70%, and 90% compressive strains, the height of arches gradually 
decreased for both types of scaffolds. After release of compressive strain, the arches can 
almost return to their original shapes for GelMA-coated scaffolds (Figure 3g). In contrast, 
the arches in 3D expanded nanofiber scaffolds without GelMA coating failed to completely 
recover after strain release (Figure 3f). We speculate that the shape recoverable property 
could be due to the unique structure of 3D expanded nanofiber scaffolds that have 
hierarchically layered architectures forming numerous arches in micro-and millimeter scale. 
These arches act as elastic units and the GelMA coatings after crosslinking further reinforce 
the arches. Upon the compressive stress, the distortion of scaffolds is mainly attributed to the 
squeezing of the arches. The continuous compression causes the densification of arches. The 
top and bottom walls of arches eventually contact with each other and form the significant 
loading-bearing portion. The cross-linked GelMA coatings may help hold the nanofibers 
together at crossing points, nodes, and contacting surfaces, thus providing strong -fatigue 
resistance. Therefore, 0.05% GelMA coated nanofiber scaffolds can fully recover their 
shapes and retain their structural integrity in each compress-release cycle in different strains. 
Compared to 0.5% gelatin-coated nanofiber scaffold, 0.05% GelMA-coated nanofiber 
scaffolds showed a better superelastic property based on the cyclic compression test,25 
which could be attributed to the intersecting hybrid nanofiber networks. In contrast, in 0.5% 
gelatin-coated nanofiber scaffolds, some pores may be blocked by the coated gelatin, 
resulting in the reduction of its superelastic property.
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We further cultured different types of cells on 0.05% GelMA-coated, 3D expanded nanofiber 
scaffolds (2 cm × 2 cm × 1.5 mm). Green fluorescence protein (GFP)-labeled dermal 
fibroblasts were first seeded on 0.05% GelMA-coated, 3D expanded nanofiber scaffolds. It 
is evident that the seeded and proliferated fibroblasts were elongated along the direction of 
nanofiber alignment after incubation for 1, 3, 7, and 14 days (Figure S3a). Besides, the 
seeded fibroblasts proliferated rapidly on the nanofiber scaffolds from day 1 to day 14 as 
indicated by cell densities contributed by the fluorescence signals and the quantified CCK-8 
assay (Figure S3a and Figure S3b). The cells entirely covered the scaffolds after 14 days of 
culture (Figure S3c). BMSCs have been used in repairing and regenerating many tissue 
types.33,34 We then demonstrated the attachment and proliferation of BMSCs on 0.05% 
GelMA-coated, 3D expanded nanofiber scaffolds. Figure 4a shows confocal microscopy 
images of the BMSCs throughout the four regions of scaffolds labeled in Figure S4 after 14 
days of incubation. The cell F-actin was stained with Alexa Fluor™ 546 Phalloidin in red, 
and the cell nucleus was stained with 4’,6-diamidino-2-phenylindole (DAPI) in blue (Figure 
4a). In addition, hNSCs have shown potential in treatment of disease or injuries of the 
central and peripheral nervous systems.35,36 We then demonstrated the proliferation and 
differentiation of hNSCs on 0.05% GelMA-coated, 3D expanded nanofiber scaffolds. The 
hNSCs were able to cover most of the area of the scaffolds after 7 days of proliferation and 
14 days of differentiation (Figure 4b). Most neurites extended along the direction of 
nanofiber alignment. Some neurites may cross through the nanofiber layers (Figure 4b).
We finally examined the effect of minimally invasive delivery on the viability of cells in 3D 
shape-recoverable tissue constructs. BMSCs were seeded on 0.05% GelMA-coated, 3D 
expanded nanofiber scaffolds (4 cm × 2 cm × 1.5 mm). These cells proliferated for 14 days 
to form 3D tissue constructs which were then compressed and loaded into a glass tube 
(diameter = 4 mm; length = 15 cm) with assistant of sharp tweezers (Figure 5a). One end of 
the glass tube was connected to a filtered air source, and the compressed, BMSCs-seeded 
scaffold inside the glass tube was blown into a culture dish containing medium and re-
expanded (Figure 5a and Video S2). No significant difference was observed between the cell 
viabilities of BMSCs on scaffolds before and after delivery (Figure 5b and Figure 5c). 
Similarly, the hNSCs-seeded nanofiber scaffolds can be delivered through the same method 
(Video S3). Alternatively, culture medium or saline flowing through the glass tube was able 
to push the compressed, cell-seeded scaffolds to the targeted tissue as well (Video S4).
In summary, we have demonstrated the fabrication of 0.05% GelMA-coated, 3D expanded 
nanofiber scaffolds. Such scaffolds were superelastic and shape recoverable. These scaffolds 
after seeding with different cell types can form 3D tissue constructs with ordered structure. 
Importantly, these 3D tissue constructs can be delivered via a minimally invasive approach 
without compromising the viability of seeded cells. Future studies will be focused on the 
investigation of the efficacy of 3D tissue constructs consisting of cells and 0.05% GelMA-
coated, 3D expanded nanofiber scaffolds in relevant large animal models.31 In addition, 
signaling molecules can be further incorporated to the nanofiber scaffolds to regulate cell 
response and enhance tissue repair.30 3D bioprinting could be used to pattern cells 
throughout the shape-recoverable nanofiber scaffolds.37 The strategy presented in this study 
holds great promise for repairing and regenerating tissues (e.g., heart) using minimally 
invasive surgical procedures.
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PCL (Mw= 80 kDa), pluronic-F-127, gelatin, sodium borohydride, Triton X-100 were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). Dichloromethane (DCM) and N, N-
dimethylformamide (DMF) were purchased from BDH Chemicals (Dawsonville, GA, USA). 
Dulbecco's modified eagle medium (DMEM), fetal bovine serum (FBS), and penicillin-
streptomycin were obtained from Invitrogen (Carlsbad, CA, USA). Basic fibroblast growth 
factor (FGF-2), epidermal growth factor (EGF), brain-derived neurotrophic factor (BDNF), 
glial cell-derived neurotrophic factor (GDNF) were obtained from Peptrotech (Rocky Hill, 
NJ, USA). The ReNcell Neural Stem Cell Medium was purchased from Millipore (Billerica, 
MA, USA). Tuj1 primary antibody and laminin were obtained from Millipore Sigma 
(Burlington, MA, USA). Goat anti-mouse IgG H&L (Alexa Fluor® 546) secondary 
antibody, Alexa Fluor™ 546 Phalloidin, DAPI were ordered from Abcam (Cambridge, MA, 
USA).
Fabrication of 0.05% GelMA coated, 3D expanded nanofiber scaffolds.
The PCL/0.5% F-127 nanofiber mat was prepared following our previous study.28-30 The 
nanofiber mat (thickness = 1 mm) was immersed in liquid nitrogen and then cut into stripes 
(4 cm × 1.5 mm × 1 mm). The nanofiber stripes were subsequently immersed into the 1 M 
NaBH4 solution and treated with vacuum for 3 s. The fiber mats were continuously 
expanded in the 1 M NaBH4 solution for another 30 s at ambient condition. The expanded 
nanofiber scaffolds were placed into a 3D printed mold (4 cm × 2 cm × 1.5 mm), treated 
with vacuum until they froze, and dried by freeze-drying. For GelMA coating, the freeze-
dried expanded nanofiber scaffolds were immersed in the 0.05% GelMA solution plus with 
0.1% 2959 photocrosslinker which was added into the mold. Then, the scaffolds were 
crosslinked with UV light for 45 s and dried by freeze-drying.
SEM characterization.
The 3D expanded nanofiber scaffolds with or without 0.05% GelMA coating were coated 
with Pt for 5 min using a Pt sputter coater and imaged by SEM under 25 kV (FEI, Quanta 
200, Hillsboro, OR, USA). Aluminum sheets confined the nanofiber scaffolds in different 
compressive strains during the SEM imaging.
Cyclic compression tests.
The mechanical properties of 3D expanded nanofiber scaffolds with or without 0.05% 
GelMA coating were measured by an Instron 5640 universal test machine. Samples (10 mm 
× 10 mm × 10 mm) were used to perform the cyclic compressive tests. The compressive 
strains were set as 50%, 70%, and 90%, respectively. The mechanical tests were run 1 cycle 
with a speed of 9 mm/min. The superelastic property of 0.05% GelMA-coated, 3D expanded 
nanofiber scaffolds were run 100 cycles with a speed of 9 mm/min under 90% compressive 
strain. The elastic modulus was obtained based on the initial slope before 30% of 
compressive strain. The recovery rate was calculated using the following equation. Recovery 
rate (%) = (pore size after expansion / pore size before expansion) ×100 %
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The GFP-labeled human dermal fibroblasts were maintained in the low glucose DMEM 
medium containing 10% FBS and 1% penicillin-streptomycin. Twenty milliliters of 
fibroblast suspension solution (1×107 cells/ml) was first prepared. The 0.05% GelMA-
coated, 3D expanded nanofiber scaffolds were put into the cell suspension solution and 
treated with vacuum for 10 s. These nanofiber scaffolds were then removed from the cell 
solution and placed into a 0.1% agar pretreated 6-well plate. The cell-seeded nanofiber 
scaffolds were continuously cultured for 1, 3, 7, and 14 days. At each indicated time point, a 
part of the scaffold (5 mm × 5mm) was cut by scissors, then it was put into a 24-well culture 
plate, added 20 μl CCK-8 and continuously cultured for 3 h. The absorbance value at 450 
nm was measured by a microplate reader.
BMSCs culture.
The rat BMSCs were isolated based on our established protocols and maintained in the low 
glucose DMEM medium containing 10% FBS and 1% penicillin-streptomycin.30 Twenty 
milliliters of BMSCs suspension solution (1×107 cells/ml) was prepared. The 0.05% 
GelMA-coated, 3D expanded nanofiber scaffolds were put into the cell suspension solution 
and treated with vacuum for 10 s. These nanofiber patch scaffolds were then removed from 
the cell solution and placed into a 0.1% agar pretreated 6-well plate. The nanofiber patch 
scaffolds were continuously cultured for 1, 3, 7, and 14 days respectively.
Human NSC culture.
Human NSCs were obtained from Millipore (Billerica, MA, USA). Laminin (20 μg/ml, 
Invitrogen) was used to coat tissue culture plastic-ware at least 4 h before cell seeding to 
promote the attachment of hNSCs. Cells were maintained in ReNcell Neural Stem Cell 
Medium (Millipore) with FGF-2 (20 ng/ml) and EGF (20 ng/ml) at 37 °C under 5% CO2. 
Then, 20 ml of hNSCs suspension with a concentration of 1×107 cell/ml were first prepared. 
The 0.05% GelMA-coated, 3D expanded nanofiber scaffolds were immersed in the cell 
suspension solution and treated with a vacuum for 10 s. The nanofiber scaffolds were then 
removed from the cell solution and placed into a 0.1% agar pretreated 6-well plate, and 
continuously cultured for 1 week. The culture medium was changed every two days. Then, 
hNSCs were cultured in the medium in the presence of BDNF (20 ng/ml) and GDNF (20 
ng/ml) for neuronal differentiation for another two weeks.
Confocal imaging.
The GFP-labeled dermal fibroblasts seeded nanofiber scaffolds were directly imaged by 
confocal laser scanning microscopy (CLSM) (Zeiss 880, Oberkochen, Germany) after 
fixation with 4% paraformaldehyde. The BMSCs seeded nanofiber scaffolds were fixed with 
4% paraformaldehyde and permeabilized with a 0.1% Triton X-100 solution. Subsequently, 
the BMSCs were stained with Alexa Fluor™ 546 Phalloidin (dilution 1:200) for 20 min and 
DAPI (dilution 1:2000) for 5 min. Then, the BMSCs seeded nanofiber scaffolds were 
imaged by confocal microscopy. The hNSCs seeded nanofiber scaffolds were fixed with 4% 
paraformaldehyde and permeabilized with 0.1% Triton X-100 in PBS solution for 20 min. 
Next, the whole scaffolds were blocked with 5% goat serum for 30 min. The cells were then 
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incubated with Tuj1 (1:100) primary antibody overnight, followed by incubation with goat 
anti-mouse IgG H&L (Alexa Fluor® 546) secondary antibody (dilution 1:200) for 1 h and 
DAPI (dilution 1:2000) for 5 min. Finally, cells-seeded scaffolds were imaged by confocal 
microscopy. The confocal microscopy imaging parameters were set as follows. The z-stack 
range was set from 0 μm to 125 μm. The interval was set at 5 μm. The tile scans were set as 
7×7 for one region of the scaffold, and four regions of the scaffolds were imaged as shown 
in Figure S4.
Demonstration of minimally invasive delivery.
The glass tube for minimally invasive delivery was modified from Wilmad® NMR tube 
(inner diameter = 4 mm). The BMSCs and hNSCs seeded nanofiber scaffolds (4 cm × 2 cm 
× 1.5 mm) were compressed and loaded into the glass tube. Then, one end of the tube was 
connected to an air source. The BMSCs and hNSCs seeded nanofiber scaffolds were pushed 
into a culture dish containing medium. The viability of BMSCs and hNSCs before and after 
delivery were evaluated by LIVE/DEAD assay. The BMSCs and hNSCs seeded nanofiber 
scaffolds were incubated with LIVE/DEAD assay kit for 10 min, and then the scaffolds were 
imaged under the confocal microscope. The cells stained with red color (dead cells) and all 
cells in each image were counted, the apoptotic ratio of cells was calculated as following, 
the apoptotic ratio (%) = (number of dead cells / number of all cells) %. Five randomly 
selected images were used to quantify the apoptotic ratio.
Statistical analysis.
All data were presented as mean ± standard deviation. The statistical analysis was performed 
using GraphPad Prism 8.0 software. Differences between the two groups were evaluated 
using Student’s t-test. The values of p < 0.05 were considered statistically significant. The 
values of p < 0.01 were considered statistically very significant.
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Schematic illustrating the fabrication of shape-recoverable 3D tissue constructs, and their 
minimally invasive delivery. Procedures of fabrication of shape-recoverable 3D tissue 
constructs and their minimally invasive delivery include generation of electrospun nanofiber 
mat, expansion of nanofiber mat, GelMA coating, crosslinking, cell seeding, compression of 
3D tissue constructs, loading into a cannula, injection, and shape-recovery.
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3D expanded nanofiber scaffold fabrication and characterization. (a) Photograph showing 
PCL nanofiber stripes (4 cm × 1.5 mm × 1 mm) before expansion. (b) Photograph showing a 
3D expanded PCL nanofiber scaffold (4 cm × 1.5 mm × 2 cm). (c) SEM images showing 3D 
expanded PCL nanofiber scaffolds without 0.05% GelMA coating, indicating the porous and 
layered structure. (d) SEM images showing 3D expanded PCL nanofiber scaffolds with 
0.05% GelMA coating, indicating the formation of hybrid nanofiber scaffolds with a porous 
and layered structure. Red arrows indicate the direction of fiber alignment. Green arrow 
heads indicate the formation of GelMA nanofibers.
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The superelastic and shape recoverable properties of 0.05% GelMA-coated, 3D expanded 
PCL nanofiber scaffolds. (a) Photographs showing the flexible properties of 0.05% GelMA-
coated, 3D expanded PCL nanofiber scaffolds. Cyclic compressive tests of 3D expanded, 
PCL nanofiber scaffolds without (b) and with (c) 0.05% GelMA coating in 90% compressive 
strain (100 cycles). (d) The maximum compressive stress of 3D expanded, PCL nanofiber 
scaffolds without and with 0.05% GelMA coating in 50%, 70%, and 90% compressive 
strain. (e) The elastic modulus of 3D expanded, PCL nanofiber scaffolds without and with 
0.05% GelMA coating after the 1st, 25th, 50th, 75th, and 100th cyclic compression. SEM 
images showing the corresponding 3D expanded, PCL nanofiber scaffolds without (f) and 
with 0.05% GelMA coating (g) before compression, in different compressive strains, and 
after release of compressive strains. 3D expanded, PCL nanofiber scaffolds without 0.05% 
GelMA coating failed to completely recover the shape after release of compressive strains. 
3D expanded PCL nanofiber scaffolds with 0.05% GelMA coating could fully recover after 
release of compressive strains. Red dot lines indicate the contours of pores before 
compression. Green dot lines indicate the original shapes of pores after compression and 
release of compressive strain.
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Cell culture on 3D expanded nanofiber scaffolds (2 cm × 2 cm ×1.5 mm). (a) Conformal 
microscopy images showing BMSCs in different regions of square-shaped nanofiber 
scaffolds. The depth imaged was 125 μm. Inset: highly magnified images of BMSCs seeded 
on nanofiber scaffolds. Cells were stained with Alexa Fluor™ 546 Phalloidin in red, and cell 
nuclei were stained with DAPI in blue. (b) Conformal microscopy images showing hNSCs 
in different regions of square-shaped nanofiber scaffolds after proliferation for 7 days and 
neuronal differentiation for another 14 days. Inset: The formation of 3D neuronal networks 
on the scaffolds after neuronal differentiation for 14 days. Cells were stained with Tuj1 for 
neurons in red, and cell nuclei were stained with DAPI in blue.
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Demonstration of minimally invasive delivery of 3D tissue constructs and the effect of 
delivery on the cell viability. (a (i)) Photograph showing a 3D tissue construct consisting of 
0.05% GelMA-coated, 3D expanded nanofiber scaffolds seeded with BMSCs in a petri dish. 
(a (ii, iii)) Photographs showing glass tubes for injection of 3D tissue constructs. (a (iv, v)) 
Photographs showing the 3D tissue construct was loaded into the glass tube and then 
injected into the petri dish containing culture medium using an air source. (a (vi)) 
Photograph showing the injected 3D tissue construct returned to its original shape. (b) LIVE/
DEAD staining of BMSCs seeded on 0.05% GelMA-coated, 3D expanded nanofiber 
scaffolds before and after injection. (c) Quantification of live BMSCs before and after 
injection.
Chen et al. Page 15
ACS Biomater Sci Eng. Author manuscript; available in PMC 2021 August 06.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
